This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 ...

Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among chronic kidney disease patients at risk for progression. HealthDay News — Empagliflozin continues to ...

Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression. HealthDay News — Empagliflozin continues to offer cardiorenal benefits ...

What is staphylococcal scalded skin syndrome in children? Staphylococcal scalded skin syndrome (SSSS) is a serious skin infection. The infection causes peeling skin over large parts of the body. It ...

MONDAY, Oct. 28, 2024 (HealthDay News) -- Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic kidney disease at risk for ...

William G. Herrington, M.B.B.S., from the University of Oxford in the United Kingdom, and colleagues randomly assigned 6,609 patients with chronic kidney disease to receive empagliflozin (10 mg ...

Klinefelter syndrome is a genetic condition in which a boy is born with an extra X chromosome. Instead of the typical XY chromosomes in men, they have XXY, so this condition is also called XXY ...

TCT 72: Intravascular Imagining-Guided Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating Unprotected Left Main Stenosis: The Multicenter ROCK III Study Receive the ...

Viet Le, PA-C, Intermountain Health, gives insights into the benefits cardio-renal-metabolic care models provide for patients in need. Viet Le, PA-C, Intermountain Health, shares his expertise ...

Metabolic syndrome, also known as insulin resistance syndrome or syndrome X, happens when you have a group of health conditions that put you at a greater risk of developing heart disease ...